• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

Challenges Remain For Worldwide Immunization By Vaccination

30/05/2017 by Elise De Geyter for Intellectual Property Watch Leave a Comment

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to email this to a friend (Opens in new window)
  • Click to print (Opens in new window)

Even though important milestones in the elimination of rubella and measles have been achieved worldwide, key challenges remain, presenters said during a technical briefing organised by the World Health Organization last week.

The briefing was held in the context of the annual World Health Assembly, taking place from 22-31 May.

WHA technical briefing

The WHO Department of Immunization, Vaccines and Biologicals organised the technical briefing Reaching everyone, everywhere with life-saving vaccines on 24 May. The panel discussion focused on the goals and challenges of immunization, as established in the Global Vaccine Action Plan 2011–2020.

Carissa F. Etienne, WHO regional director for the Americas, said that strong political commitment, solidarity and coordination between member states is essential to achieve the immunization goals within WHO. The biggest challenge is to retain the achievements made in the Americas in order to establish worldwide immunization of measles and rubella, she said.

WHO Director General Margaret Chan, addressing the briefing, said that it is necessary to make sure everyone is covered. Etienne highlighted that the prevention of an outbreak is less costly and disruptive than dealing with an epidemic outbreak.

Worldwide coverage by vaccination is, however, hindered by different obstacles such as regulatory requirements, logistical problems, vaccination hesitancy, and financial and political crises, several speakers said.

Chan said that we should not be too pessimistic. Some countries, including the Democratic Republic of Congo, Ethiopia and India, have been making tremendous progress in immunization programs especially in reaching vulnerable populations. Attention was drawn to Mission Indradhanush, a program of the Indian government that aims to cover 90 percent of pregnant women and children younger than two years with 11 vaccines.

Sustainable financing is a key element for successful immunization, according to a representative of Save the Children, which suggests that countries should allocate at least five percent of their gross domestic product to public health. The non-governmental organisation stressed the importance of ensuring that all children receive the necessary vaccines in time. Civil society is an important player, according to Save the Children, to speak up for communities that are left behind.

Immunization by vaccination is however not only the responsibility of the state, but also of the parents, according to Søren Brostrøm, director-general of the Danish Health Authority. He mentioned the difficulty recently experienced in Denmark in convincing parents to vaccinate their children. Despite the existing strong evidence and reporting systems, a lot of young parents delay vaccination as they do not realise the danger of diseases such as measles and polio, he said. Brostrøm concluded that immunization by vaccination is also a challenge for high-income countries.

Flavia Bustreo, WHO assistant director general for Family, Women’s and Children’s Health, said there is a similar resistance to vaccines by parents in Italy.

Elise De Geyter is an intern at Intellectual Property Watch and a candidate for the LLM Intellectual Property and Technology Law at the National University of Singapore (class 2017).

 

Image Credits: Elise De Geyter

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to email this to a friend (Opens in new window)
  • Click to print (Opens in new window)

Related

Elise De Geyter may be reached at info@ip-watch.ch.

Creative Commons License"Challenges Remain For Worldwide Immunization By Vaccination" by Intellectual Property Watch is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Filed Under: IP Policies, Language, Themes, Venues, Development, English, Health Policy Watch, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, WHA 2017, WHO

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Top Global Health stories

New WHO Director Tedros’s Opening Vision: People First

Enter The African Medicines Agency, Continent’s First Super-Regulator?

More health stories...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2021 · Global Policy Reporting

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.